市場調查報告書

兒童介入心臟病學的全球市場:成長,趨勢,及預測

Pediatric Interventional Cardiology Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 390887
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
兒童介入心臟病學的全球市場:成長,趨勢,及預測 Pediatric Interventional Cardiology Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 115 Pages
簡介

本報告提供全球兒童介入心臟病學市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的假設
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 市阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Labortories
    • Boston Scientific Corporation
    • Cardinal Health Inc
    • Edwards Lifesciences Corporation
    • GE Healthcare
    • W. L. Gore & Associates
    • Medtronic PLC
    • NuMED Inc.
    • Siemens Healthineers

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 56208

The pediatric interventional cardiology market is growing at a significant rate, due to the increasing instances of heart diseases in children and the rising technological advancements in the field. Other factors driving the pediatric interventional cardiology market include increasing awareness among the population, increased preference of minimally invasive procedures over conventional surgeries, and the rising number of congenital disorders. However, stringent regulatory policies, expensive treatments, and therapies are likely to hamper the growth of the pediatric interventional cardiology market.

Key Market Trends

Stents is Expected to Hold Significant Share in this Market

There are different types of stents available in the market for the pediatric interventional cardiology procedures. Bare Stent, drug-eluting stent, bio-absorbable stent are few among them. According to a new research study published in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions (SCAI) conducted by Rady Children's researchers found coronary stent implantation to be a feasible and safe palliative option for children fifteen months and younger.

A bare stent is used to widen any narrowed coronary artery while performing angioplasty. A bare stent is preferred if the blocked vessel is large and the blockages are small. A bare-metal stent is quite economical and helps in fast vascular healing, with no risk of thrombosis.

Drug-eluting stents are used for stenoticarteries, in order to prevent fibrosis by releasing drugs. Unlike bare stents, these help in suppressing restenosis or relocking of the artery after angioplasty and decrease the chances of repeating the angioplasty.

A bio-absorbable stent is made up of a metal or a polymer that is dissolved or absorbed into the body. It is highly advanced than, both, bare stent and drug-eluting stent. Bio-absorbable stents do not cause permanent metal prosthesis. Thrombosis and restenosis are prevented, as the stent disappears.

Asia Pacific is the fastest growing region in Pediatric Interventional Cardiology Market

North America region has the largest share in global pediatric interventional cardiology market. This can be attributed to the rising incidences of CHDs, nationwide. As per the Centre for Disease Control (CDC), congenital heart defect (CHD) is the most common type of birth defects, which affects nearly 1%, or about 40,000 births per year. The prevalence of some of the mild CHDs is increasing, while the prevalence of other types has remained stable. At least 15% of all CHDs are associated with genetic conditions. Other prime drivers are rising demand for less invasive procedure for high-risk patients, growing prevalence of mitral regurgitation, severe aortic stenosis disorder, and also factors, such as shorter recovery time, less stay in hospitals, favorable outcomes with transcatheter prosthetic valve implantation, and other technological advancements are likely to boost the growth of the Pediatric Interventional Cardiology Market in North America region.

Competitive Landscape

Market players in Global Pediatric Interventional Cardiology Market are focusing on the expansion of their product portfolios by adopting inorganic growth strategies such as acquisitions, mergers and partnerships. Major players in Global Pediatric Interventional Cardiology Market are Abbott, Boston Scientific Corporation, Cardinal Health, Edwards Lifesciences Corporation, GE Healthcare, W. L. Gore & Associates, Medtronic, NuMED Inc., and Siemens AG among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased R&D Activities Towards Development of Novel Devices
    • 4.2.2 Rising Incidences of Congenital Heart Diseases
    • 4.2.3 Technological Advancements in Pediatric Interventional Cardiology
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Procedures
    • 4.3.2 Reimbursement and Regulatory Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Closure Devices
    • 5.1.2 Transcatheter Heart Valves
    • 5.1.3 Atherectomy Devices
    • 5.1.4 Catheters
    • 5.1.5 Balloons
    • 5.1.6 Stents
    • 5.1.7 Others
  • 5.2 By Procedure
    • 5.2.1 Catheter-Based Valve Implantation
    • 5.2.2 Congenital heart defect correction
    • 5.2.3 Angioplasty
    • 5.2.4 Coronary thrombectomy
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cardinal Health
    • 6.1.4 Edwards Lifesciences Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 W. L. Gore & Associates
    • 6.1.7 Medtronic
    • 6.1.8 NuMED Inc.
    • 6.1.9 Siemens Healthneers

7 MARKET OPPORTUNITIES AND FUTURE TRENDS